The American Society for Gastrointestinal Endoscopy recently released new clinical guidance on the screening for pancreatic cancer in people with genetic susceptibility (Gastrointest Endosc 2022 Feb 16. doi:10.1016/j.gie.2021.12.001). GEN’s Sarah Tilyou spoke with lead author Mandeep S. Sawhney, MD, MS, FASGE, a gastroenterologist at Beth Israel Deaconess Medical Center and an associate professor of medicine at Harvard Medical School, in Boston, about the impetus for the guidelines and what they mean to GI practice.
Trending
- Strategic AI Mastery: The decision that changed everything — and could change GI forever sent
- GI pay by years of experience (Becker’s GI & Endoscopy)
- The providers hit hardest by the government shutdown (Advisory Board)
- It’s Not the Polyp, It’s the Provider: Study (Conexiant )
- Rideshare ‘potentially scalable intervention’ to improve colonoscopy after abnormal FIT (Healio)
- A Promising, Noninvasive Screening Tool for Colorectal Polyps (DocWire News)
- Geodemographic Trends in Private Equity Acquisitions of U.S. Gastroenterology Practices: An Analysis of Transactions From 2013 to 2023 (Clinical Gastroenterology and Hepatology)
- How AI Is Redefining Healthcare’s Front Door (Forbes)
